Business

FDA Accepts Clinical Research Underlying GLUCODOWN® Dietary Fiber Labeling

FDA Accepts Clinical Research Underlying GLUCODOWN® Dietary Fiber Labeling.

articleGlucose Health, Inc.March 13, 20193/company/glucose-health-inc/news/fda-accepts-clinical-research-underlying-glucodownr-dietary-fiber-labeling
FDA Accepts Clinical Research Underlying GLUCODOWN® Dietary Fiber Labeling

About this update from Glucose Health, Inc.

[{"type":"text","content":"\n\n\n\nFDA Accepts Clinical Research Underlying GLUCODOWN® Dietary Fiber Labeling\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nFDA Accepts Clinical Research Underlying GLUCODOWN® Dietary Fiber Labeling\nPR Newswire\nBENTONVILLE, Ark., March 13, 2019\n\n\n\nBENTONVILLE, Ark., March 13, 2019 /PRNewswire/ -- GLUCODOWN®, manufactured by Glucose Health, Inc. (OTC: GLUC), is the leading functional tea beverage in the over-the-counter diabetic nutritional retail category, which encompasses the more than 100 million Americans estimated to be diabetic or pre-diabetic.1 Food and Drug Administration (\"FDA\") regulations2 enacted in 2016, provide that only forms of dietary fiber demonstrating a \"beneficial physiological effect on human health\", can be declared on nutritional supplement product labels, as dietary fiber. More than two years ago, a citizen's petition prepared by Archer Daniels Midland was submitted to the FDA on behalf of Fibersol®-2, the trade name of the dietary fiber in GLUCODOWN®.  The FDA concluded, \"based on (its) careful review of the strength of scientific evidence\" that Fibersol®-2 meets \"our regulatory definition of dietary fiber\" as established in 2016, in Title 21 CFR 101.9(c)(6)(i).3\nThe result is GLUCODOWN® is the first instant tea mix in America, enriched with a form of soluble dietary fiber recommended by the Food & Drug Administration for inclusion in the aforementioned Title 21. More than 20 years of clinical research and 100 published studies establish the beneficial physiological impacts of the Fibersol®-2 soluble dietary fiber in GLUCODOWN®. This body of scientific evidence establishes, in particular, beneficial impacts on:\npost-prandial blood sugar levels; glucose and lipids metabolism; and, digestive health. All product labeling on containers of GLUCODOWN® Peach, Lemon and Raspberry tea mixes reference these three functional impacts in a manner that is concise and measured, with appropriate cautionary statements for the benefit of all consumers. Additionally, every ...

More updates from Glucose Health, Inc.